Hong Kong, China vs Saudi Arabia: New cases tested for RR-/MDR-TB
Hong Kong, China
96.0%
in 2024
Saudi Arabia
96.0%
in 2024
Hong Kong, China rank
67th
Saudi Arabia rank
67th
New cases tested for RR-/MDR-TB over time
- Hong Kong, China
- Saudi Arabia
How they compare
Hong Kong, China currently reports 96.0% against 96.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 1 time across 11 shared years of data; in 2013 it was Hong Kong, China ahead.
Hong Kong, China ranks 67th and Saudi Arabia ranks 67th of 192 countries.
Hong Kong, China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hong Kong, China | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.3% | 54.8% | 40.6% | Hong Kong, China |
| 2020s | 95.6% | 68.8% | 26.8% | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Hong Kong, China or Saudi Arabia?
- Hong Kong, China, at 96.0% against 96.0% in Saudi Arabia as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Hong Kong, China and Saudi Arabia?
- 0.0%, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Saudi Arabia?
- 11 years are reported by both, from 2013 to 2024.
- How do Hong Kong, China and Saudi Arabia rank globally for new cases tested for rr-/mdr-tb?
- Hong Kong, China ranks 67th and Saudi Arabia ranks 67th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.